SAC Capital Manager Arrested for Insider Trading
Founder of company also linked to scheme to profit off secret info about drug testing
US officials have linked Steven Cohen, founder of SAC Capital, one of Wall Street's most powerful hedge funds, to an insider-trading scheme that prosecutors called the most lucrative case of its kind.
US prosecutors charged Mathew Martoma, a former portfolio manager at CR Intrinsic, a SAC Capital fund, with trading shares in two pharmaceuticals companies after obtaining secret information about a clinical drug trial. US authorities alleged that Mr Martoma recommended trading shares in Elan and Wyeth to the "hedge fund owner", who people familiar with the matter confirm was Mr Cohen.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?